XML 59 R38.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Financial Information of The Parent Company (Tables)
12 Months Ended
Dec. 31, 2020
Condensed Financial Information Disclosure [Abstract]  
Schedule of balance sheets
    As of December 31,  
    2019     2020     2020  
    RMB     RMB     USD  
ASSETS                        
Current assets                        
Cash and cash equivalents     35       183       28  
Prepaid expenses and other current assets     -       392       60  
Amounts due from subsidiaries     -       236,403       36,231  
Total current assets     35       236,978       36,319  
                         
Non-current assets                        
Investments in subsidiaries and consolidated VIE     174,525       359,394       55,081  
                         
TOTAL ASSETS     174,560       596,372       91,400  
                         
LIABILITIES AND SHAREHOLDERS’ EQUITY                        
Current liabilities                        
Amounts due to subsidiaries     34       -       -  
Warrant liabilities     -       29,558       4,530  
Current portion of contingent consideration – earn-out liability     -       92,183       14,128  
Total current liabilities     34       121,741       18,658  
Non-current liabilities                        
Contingent consideration – earn-out liability     -       15,116       2,317  
Total liabilities     34       136,857       20,975  
                         
Shareholders’ equity                        
Ordinary share, no par value, unlimited shares authorized, 19,400,000 and 27,037,302 shares issued and outstanding as of December 31, 2019 and 2020, respectively     9,664       (96,349 )     (14,766 )
Shares to be issued     -       200,100       30,667  
Statutory reserves     12,059       18,352       2,813  
Retained earnings     152,803       322,610       49,442  
Accumulated other comprehensive income     -       14,802       2,269  
Total shareholder’s equity     174,526       459,515       70,425  
                         
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY     174,560       596,372       91,400  
Schedule of statements of comprehensive loss
   For the years ended December 31, 
   2018   2019   2020   2020 
   RMB   RMB   RMB   USD 
Equity income of subsidiaries   106,740    149,918    184,869    28,333 
General administrative expense and others   -    -    1,395    214 
Change in fair value of warrant liabilities   -    -    3,904    597 
Change in fair value of contingent consideration   -    -    (14,068)   (2,156)
Net income   106,740    149,918    176,100    26,988 
Other comprehensive income - foreign currency translation adjustment   -    -    14,802    2,269 
Comprehensive income attributable to the Company’s shareholders   106,740    149,918    190,902    29,257 
Schedule of statements of cash flows
   For the years ended December 31, 
   2018   2019   2020   2020 
   RMB   RMB   RMB   USD 
Cash flows from operating activities                
Net income   106,740    149,918    176,100    26,988 
Equity in earning of subsidiaries   (106,740)   (149,918)   (184,869)   (28,332)
Change in fair value of warrant liabilities   -    -    (3,904)   (598)
Change in fair value of contingent consideration   -    -    14,068    2,156 
Changes in operating assets and liabilities   -    -    -    - 
Prepaid expense and other current assets   -    -    (392)   (60)
Net cash provided by operating activities   -    -    1,003    154 
                     
Cash flows from investing activities                    
Proceeds from subsidiaries   238,500    136,953    -    - 
Net cash provided by investing activities   238,500    136,953    -    - 
                     
Cash flows from financing activities                    
Dividends distribution to shareholders   (228,500)   (104,590)   -    - 
Capital distribution due to reorganization   (10,000)   (32,328)   -    - 
Due to related parties   -    -    (26,590)   (4,075)
Net cash acquired in the reverse recapitalization   -    -    32,659    5,005 
Payment of listing costs   -    -    (6,924)   (1,061)
Net cash used in financing activities   (238,500)   (136,918)   (855)   (131)
                     
Net increase in cash and cash equivalents   -    35    148    23 
Cash and cash equivalents at beginning of the year   -    -    35    5 
Cash and cash equivalents at end of the year   -    35    183    28